ReviewOncology reviews2026

Blood-based inflammatory biomarkers in ovarian cancer: addressing the challenge of early detection, metastasis, and prognostic stratification.

Emmanuel Ifeanyi ObeaguPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.